FDA Inspection
Sherwyn L Schwartz, M.D.Sherwyn L Schwartz, M.D. – FDA Inspection, Sep 16, 2009
Record Details
This FDA Inspection record concerns Sherwyn L Schwartz, M.D., with an inspection on September 16, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sherwyn L Schwartz, M.D.
- Inspection Date
- September 16, 2009
- Product Type
- Drugs
View Company Profile
ID · f4dfd0f6-9ac9-40b6-a98b-839d014fb567
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 621261
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Unanticipated problems
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sherwyn L Schwartz, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sherwyn L Schwartz, M.D.
- FDA Inspection 791030 - 2012-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.